Novartis fails to patent Glivec (Gleevec) in India
Keep ReadingGlivec (sometimes Gleevec) is a cancer treatment drug which is patented in over 40 other countries including China, Russia,...
EU Science: Global Challenges Global Collaboration Conference in the European Parliament
Keep Reading4-8 March 2013 – EU Science: Global Challenges Global Collaboration Conference in the European Parliament Anna Duch, PhD (Associate,...
The commercial innovation league table for graphene – the World’s Top 10 Graphene Patent Owners
Keep ReadingCambridgeIP’s analysis of the densely populated graphene IP Landscape® is conducted on CambridgeIP’s extensive global patent database, using CambridgeIP’s…
IP strategy in the era of blockbuster patent expirations
Keep ReadingIn the decade of intensive blockbuster patent expirations pharmaceutical companies apply different IP strategies to protect their revenues by…
Surge in interest in wonder-material graphene
Keep ReadingCambridgeIP research for the period to 31st December 2012 shows a surge in graphene patent filings starting around 2007....